Handugan, Rosalina A.
HRN: 11-32-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/19/2022
08/25/2022
IV
2.25gm
Q8
Urinalysis UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose Wrong Dose
Overall appropriateness: No Wrong Dose